Your browser doesn't support javascript.
loading
Physicochemical stability of pevonedistat at 50, 100 and 200 µg/mL diluted in 0.9% sodium chloride and at 10 mg/mL in partially used vials.
Doncheva, Ralitsa; D'Huart, Elise; Sobalak, Nathalie; Vigneron, Jean; Demoré, Béatrice.
Affiliation
  • Doncheva R; Pharmacy, CHU Nancy Pharmacy, Vandoeuvre lès Nancy, France ralitsa.doncheva@yahoo.com E.D'HUART@chru-nancy.fr.
  • D'Huart E; Pharmacy, CHU Nancy Pharmacy, Vandoeuvre lès Nancy, France ralitsa.doncheva@yahoo.com E.D'HUART@chru-nancy.fr.
  • Sobalak N; Non-profit Association, Infostab, Heillecourt, France.
  • Vigneron J; Pharmacy, CHU Nancy Pharmacy, Vandoeuvre lès Nancy, France.
  • Demoré B; Pharmacy, CHU Nancy Pharmacy, Vandoeuvre lès Nancy, France.
Eur J Hosp Pharm ; 2024 Feb 26.
Article in En | MEDLINE | ID: mdl-38408796
ABSTRACT

OBJECTIVES:

Pevonedistat is a new cytotoxic used in association with azacitidine for the treatment of acute myeloid leukaemia and high-risk myelodysplastic syndromes. The manufacturer indicates an 18-hour stability after dilution in dextrose 5% or 0.9% sodium chloride (0.9% NaCl) at 2-8°C. No information is given for re-using vials of pevonedistat.Our objectives were to study the physico-chemical stability of 50 and 200 µg/mL pevonedistat diluted in 0.9% NaCl, in glass tubes, 100 µg/mL in 0.9% NaCl in polyolefin infusion bags, and 10 mg/mL partially used vials with a Spike. All preparations were stored at 2-8°C, protected from light. MATERIALS AND

METHODS:

Due to the limited quantity of pevonedistat available for this study, we prepared test solutions at 50 and 200 µg/mL in glass tubes in a small volume of 20 mL. Inorder to verify the absence of a sorption phenomenon of the molecule onto polyolefin, we prepared two infusion bags at 100 µg/mL. We tested concentrated solution at 10 mg/mL. At each analysis time, we tested three samples of each condition by high performance liquid chromatography (HPLC) coupled with a photodiode array detector. Physical stability was evaluated by a visual and sub-visual inspection. We measured pH at each analysis time.

RESULTS:

Diluted solutions at 50 and 200 µg/mL in tubes and at 100 mg/mL in infusion bags retained more than 95% of the initial concentration for 14 days, the concentrated solution at 10 mg/mL did so for 7 days. No physical changes were detected visually or sub-visually. We found that pH values remained stable.

CONCLUSION:

All diluted solutions remained physically and chemically stable for 14 days, the concentrated solution did so for 7 days. No interactions between the polyolefin bag and pevonedistat were demonstrated. This new data allows re-using the concentrated solution of pevonedistat in a commercial glass vial with a Spike, and storing a preparation in case of non-administration.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Eur J Hosp Pharm Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Eur J Hosp Pharm Year: 2024 Document type: Article